Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SUVN-4404091 shows efficacy in rat model of amphetamine-induced hyperlocomotion

Nov. 11, 2021

Frequency Therapeutics unveils new research program for hearing loss and MS

Nov. 10, 2021

Cybin reports positive preclinical data on deuterated psilocybin analogue

Nov. 9, 2021

Brain infections rare but brain symptoms common with SARS-CoV-2

Nov. 9, 2021

GABAergic interneuron progenitors from iPSCs improve signs of experimental Alzheimer's disease

Nov. 5, 2021

Parkinson's disease model confirms metabolic, contests anatomic tenets

Nov. 5, 2021

Japanese researchers disclose new SPR inhibitors

Nov. 5, 2021

Disarm Therapeutics discloses SARM1 inhibitors

Nov. 4, 2021

Angelman syndrome gene therapy restores dual-isoform expression of UBE3A in the developing brain

Nov. 3, 2021

FTD3-associated reactive astrocytes display autophagy impairments and cause neuronal toxicity

Nov. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...